Quantum-Si incorporated (QSI)

Market Cap	225.02M -23.6%
Revenue (ttm)	2.44M -20.3%
Net Income	-101.34M
EPS	-0.51
Shares Out	216.37M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,474,558
Open	0.940
Previous Close	0.926
Day's Range	0.935 - 1.100
52-Week Range	0.842 - 3.100
Beta	3.08
Analysts	Buy
Price Target	1.00 (-3.85%)
Earnings Date	Mar 3, 2026

About QSI

Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). The company offers Platinum and Platinum Pro NGPS instruments for single-molecule, amino acid level resolution, and automated data analysis; library preparation kits to prepare a customer’s protein sample for sequencing; and sequencing kits, which contain the reagents and consumables used to perform NGPS. It also provides Platinum analysis software, a cloud-...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2013
• Employees: 145
• Stock Exchange: NASDAQ
• Ticker Symbol: QSI
• Website: https://www.quantum-si.com

Financial Performance

In 2025, Quantum-Si incorporated's revenue was $2.44 million, a decrease of -20.34% compared to the previous year's $3.06 million. Losses were -$101.34 million, 0.33% more than in 2024.

Analyst Summary

According to 2 analysts, the average rating for QSI stock is "Buy." The 12-month stock price target is $1.0, which is a decrease of -3.85% from the latest price.

Price Target

$1.0

(-3.85% downside)

Analyst Consensus: Buy